Viewing nowSaporidin Tablets (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Sears Pharmaceutical Co., Ltd.

MFDS item code 202003339 · Approved 2020.05.08 · Insurance code 689001300
Improvement of ischemic symptoms such as chronic arterial occlusion (ulcers, pain)
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness caused by chronic arterial occlusion. Representative diseases include Buerger's disease, occlusive arterial sclerosis, and diabetic peripheral vascular disease. This medication aids in improving blood circulation and alleviating discomforting symptoms. Therefore, it helps improve symptoms due to chronic vascular problems.
Adults: Administer 100 mg of Sarpogrelate Hydrochloride orally three times a day after meals. Adjust accordingly based on symptoms.
This medication should not be used in patients with bleeding as it may increase the risk of bleeding. It is advisable for pregnant women or women who may become pregnant to avoid taking this medication. Patients with genetically inherited lactose intolerance should not take this medication due to the presence of lactose. Women who are menstruating or have a tendency to bleed should use this medication with caution, and patients taking anticoagulants or antiplatelet agents should be careful due to heightened bleeding risks. Patients with severe renal impairment or elderly individuals should be administered this medication cautiously as it may affect drug excretion or metabolism. During the use of this medication, it is essential to closely monitor for bleeding symptoms, liver function abnormalities, and blood dyscrasias; should any abnormal symptoms occur, administration should be immediately discontinued and medical consultation sought. Regular blood tests during the course of this medication are recommended. Caution is required when coadministered with anticoagulants or antiplatelet agents as it may increase bleeding risk. Pregnant or breastfeeding women should preferably avoid this medication, and if it is essential to take, breastfeeding should be avoided. Safety in pediatric patients has not been established, and thus experience of use is lacking. For elderly patients, the concentration of the medication may increase due to decreased renal and liver function, therefore administration should begin at a low dose, and conditions should be observed closely. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may pose an accident risk and lead to quality degradation.
Gastrointestinal bleeding (such as hematemesis and melena), cerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, urticaria
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Sears Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.